ES541930A0 - Procedimiento de obtener un preparado virico contra la enfermedad de marek. - Google Patents

Procedimiento de obtener un preparado virico contra la enfermedad de marek.

Info

Publication number
ES541930A0
ES541930A0 ES541930A ES541930A ES541930A0 ES 541930 A0 ES541930 A0 ES 541930A0 ES 541930 A ES541930 A ES 541930A ES 541930 A ES541930 A ES 541930A ES 541930 A0 ES541930 A0 ES 541930A0
Authority
ES
Spain
Prior art keywords
disease
marek
virus
mdv
monovalent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES541930A
Other languages
English (en)
Other versions
ES8605680A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centraal Diergeneeskundig Instituut
Original Assignee
Centraal Diergeneeskundig Instituut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centraal Diergeneeskundig Instituut filed Critical Centraal Diergeneeskundig Instituut
Publication of ES541930A0 publication Critical patent/ES541930A0/es
Publication of ES8605680A1 publication Critical patent/ES8605680A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES541930A 1984-04-09 1985-04-03 Procedimiento de obtener un preparado virico contra la enfermedad de marek. Expired ES8605680A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8401120A NL8401120A (nl) 1984-04-09 1984-04-09 Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.

Publications (2)

Publication Number Publication Date
ES541930A0 true ES541930A0 (es) 1986-04-16
ES8605680A1 ES8605680A1 (es) 1986-04-16

Family

ID=19843774

Family Applications (1)

Application Number Title Priority Date Filing Date
ES541930A Expired ES8605680A1 (es) 1984-04-09 1985-04-03 Procedimiento de obtener un preparado virico contra la enfermedad de marek.

Country Status (17)

Country Link
US (1) US4673572A (es)
EP (1) EP0159743B1 (es)
JP (1) JPS6123A (es)
AT (1) ATE56364T1 (es)
AU (1) AU574164B2 (es)
CA (1) CA1251397A (es)
DD (1) DD232822A5 (es)
DE (1) DE3579617D1 (es)
ES (1) ES8605680A1 (es)
HU (1) HU194496B (es)
IL (1) IL74809A (es)
IN (1) IN163229B (es)
MX (1) MX7718E (es)
NL (1) NL8401120A (es)
WO (1) WO1985004588A1 (es)
YU (1) YU44687B (es)
ZA (1) ZA852564B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456101A (en) * 1980-11-08 1984-06-26 Honda Giken Kogyo Kabushiki Kaisha Vehicular brake operating system
JP2508625B2 (ja) * 1985-08-30 1996-06-19 ソニー株式会社 半導体レ−ザ−
FR2598596B1 (fr) * 1986-05-15 1990-10-19 Sanofi Elf Bio Ind Procede de traitement du lait en vue de l'obtention de fromages
US5849299A (en) * 1991-06-28 1998-12-15 The United States Of America As Represented By The Secretary Of Agriculture Attenuated revertant serotype 1 marek's disease vaccine
WO1993023078A1 (en) * 1992-05-19 1993-11-25 Viktoria Alexeevna Lukina Vaccine for prophylaxis of marek disease of birds and method of its preparation
IL114501A (en) * 1994-07-14 1999-08-17 Akzo Nobel Nv Marek's disease virus vaccine
EP0703294A1 (en) * 1994-07-14 1996-03-27 Akzo Nobel N.V. Marek's disease virus vaccine
EP0748867A1 (en) * 1995-06-12 1996-12-18 Duphar International Research B.V Marek's disease vaccine
US5989805A (en) * 1995-10-27 1999-11-23 Board Of Trustees Operating Michigan State University Immortal avian cell line to grow avian and animal viruses to produce vaccines
WO1997046103A1 (en) * 1996-06-04 1997-12-11 University Of Georgia Research Foundation, Inc. Modified live avian polyomavirus vaccine in psittacine birds
EP1038952A3 (en) * 1998-12-09 2001-06-27 Pfizer Products Inc. Processes for preparation of Marek's Disease Virus using continuous avian cell lines
RU2144377C1 (ru) * 1999-06-28 2000-01-20 Всероссийский научно-исследовательский институт защиты животных Бивалентная вакцина против болезни марека и способ ее изготовления
MY169061A (en) 2012-03-22 2019-02-12 Merial Inc Modified marek's disease virus, and vaccines made therefrom

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292803A (en) * 1968-11-18 1972-10-11 Nat Res Dev Improvements relating to the production of antigens
US3642574A (en) * 1970-04-29 1972-02-15 Us Agriculture Method for producing vaccine for immunization of poultry against marek{3 s disease
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine

Also Published As

Publication number Publication date
EP0159743B1 (en) 1990-09-12
IL74809A0 (en) 1985-07-31
HUT38542A (en) 1986-06-30
US4673572A (en) 1987-06-16
DE3579617D1 (de) 1990-10-18
ZA852564B (en) 1985-11-27
JPS6123A (ja) 1986-01-06
DD232822A5 (de) 1986-02-12
CA1251397A (en) 1989-03-21
ES8605680A1 (es) 1986-04-16
ATE56364T1 (de) 1990-09-15
MX7718E (es) 1990-10-10
IN163229B (es) 1988-08-27
AU4156185A (en) 1985-11-01
YU44687B (en) 1990-12-31
WO1985004588A1 (en) 1985-10-24
JPH0317808B2 (es) 1991-03-11
IL74809A (en) 1990-09-17
AU574164B2 (en) 1988-06-30
EP0159743A1 (en) 1985-10-30
NL8401120A (nl) 1985-11-01
HU194496B (en) 1988-02-29
YU59985A (en) 1988-06-30

Similar Documents

Publication Publication Date Title
ES541930A0 (es) Procedimiento de obtener un preparado virico contra la enfermedad de marek.
Powell Immunity to Marek's disease induced by glutaraldehyde-treated cells of Marek's disease lymphoblastoid cell lines
Whetstone et al. Changes in the bovine herpesvirus 1 genome during acute infection, after reactivation from latency, and after superinfection in the host animal
Allen et al. Role of coexpression of IL-2 and herpes simplex virus proteins in recombinant vaccinia virus vectors on levels of induced immunity
US5686287A (en) Marek's disease virus vaccine
Morita et al. Recombinant vaccinia virus LC16m0 or LC16m8 that expresses hepatitis B surface antigen while preserving the attenuation of the parental virus strain
US4895717A (en) Revertant serotype 1 Marek's disease vaccine
CA2185407A1 (en) Sustainable chick cell line infected with marek's disease virus
US4895718A (en) Serotype 2 Marek's disease vaccine
CA2222482A1 (en) Non-virulent mycoplasma synoviae and vaccine thereof
US5149530A (en) Live newcastle disease virus vaccines
EP0156478A3 (en) Propagation of group ii avian adeno (aa) virus in avian cell culture and vaccine produced
DZ1550A1 (fr) Vaccin depourvu de cellules contre le virus de la maladie marek.
US5565202A (en) Low enhancement serotype 2 vaccine for marek's disease
US4213965A (en) Small-plaque variant canine herpesvirus vaccine
Powell Protection against the JMV Marek's disease‐derived transplantable tumour by Marek's disease virus‐specific antigens
Morein et al. Vaccination against herpesvirus, fiction or reality
Eisenstein et al. Salmonella vaccines: Protection by endotoxin protein and lipopolysaccharide in two different mouse strains.
JPS5756430A (en) Live virus vaccine for canine parainfluenza
EP0703294A1 (en) Marek's disease virus vaccine
JP3040157B2 (ja) イヌパルボウイルス（ｃｐｖ）を含む弱毒イヌパルボウイルスワクチンとイヌ科動物におけるｃｐｖ感染予防
Jeffries et al. Atypical menaquinone pattern in a strain of Staphylococcus aureus
CA1289881C (en) Vaccine against herpes simplex
KR960016906A (ko) 약독화 수두 생바이러스 백신 및 그의 제조방법
Allison Tumour Viruses: Are Observations on Tumour Viruses in Animals Applicable to Man?